Although delayed puberty is relatively common and often familial, its molecular and pathophysiologic basis is poorly understood. In contrast, the molecular mechanisms underlying some forms of hypogonadotropic hypogonadism (HH) are clearer, following the description of mutations in the genes KAL, GNRHR, and PROP1. Mutations in another gene, DAX1 (AHC), cause X-linked adrenal hypoplasia congenita and HH. Affected boys usually present with primary adrenal failure in infancy or childhood and HH at the expected time of puberty.
this emerging phenotypic spectrum of clinical presentation in men and women with DAX1 mutations, we hypothesized that DAX1 might be a candidate gene for mutation in patients with idiopathic sporadic or familial HH or constitutional delay of puberty. Direct sequencing of DAX1 was performed in 106 patients, including 85 (80 men and 5 women) with sporadic HH or constitutional delay of puberty and patients from 21 kindreds with familial forms of these disorders. No DAX1 mutations were found in these groups of patients, although silent single nucleotide polymorphisms were identified (T114C, G498A). This study suggests that mutations in DAX1 are unlikely to be a common cause of HH or pubertal delay in the absence of a concomitant history of adrenal insufficiency. (J Clin Endocrinol Metab 84: [4497] [4498] [4499] [4500] 1999) T HE ASSOCIATION of DAX1 (AHC) gene mutations with X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HH) is well established (OMIM: 300200) (1, 2) . More than 50 different mutations in the gene encoding DAX-1 have been reported in this condition (3) (4) (5) (6) . Affected boys typically present with primary adrenal insufficiency in infancy or childhood. HH usually becomes evident later in life with failure of pubertal development (7, 8) .
DAX-1 is an orphan nuclear hormone receptor that is expressed in the adrenal gland, gonads, hypothalamus, and pituitary gonadotropes (9) . The HH caused by DAX1 mutations seems to involve deficits at both hypothalamic and pituitary levels (10 -13) . DAX-1 is also expressed in Sertoli cells (14) , and male Ahch (Dax1) knockout mice have disordered spermatogenesis and infertility (15) . DAX-1 has a crucial role, therefore, in the development and function of the reproductive axis at multiple levels. Different approaches to counseling and treatment are needed for patients with DAX1 mutations compared to those with hypothalamic forms of HH, such as Kallmann syndrome (3, 16) .
Recently, DAX1 gene mutations have been found in several men and women who have less typical reproductive phenotypes. These cases include: 1) partial HH in a man who presented later in life with mild adrenal failure (13); 2) HH, but normal adrenal function, in a woman who is homozygous for a DAX1 mutation through gene conversion (17) ; and 3) extreme pubertal delay, but normal fertility, among heterozygous female carriers of DAX1 mutations (12) . Given the phenotypic spectrum of reproductive disorders now reported, we hypothesized that DAX1 mutations might cause idiopathic familial or sporadic HH or constitutional delay of puberty (CD) among patients lacking a history of overt adrenal failure. DNA sequence analysis of over 100 such patients suggests, however, that coding sequence mutations in DAX1 are unlikely to be a common cause of such conditions.
Subjects and Methods Subjects
DAX1 was sequenced directly in 106 patients who had sporadic (nonfamilial) or familial HH (see Patient Characteristics for definitions) or CD (testicular volume Ͻ4 mL and delay of sexual maturation at 14 yr of age). Patients were not recruited if they had multiple pituitary hormone deficiencies or if a likely cause for their altered hypothalamicpituitary-gonadal (HPG) function was evident (for example, a history of tumors, cranial irradiation, or syndromes associated with HH). Mutations in the genes encoding the GnRH receptor and anosmin-1 (KAL) had been excluded in 75% and 80% of the patients, respectively.
PCR and direct sequencing of DAX1
After obtaining Institutional Review Board approval, DNA was extracted from patients' blood leukocytes using standard methods. Both exons of DAX1, their splice sites, and a 240-bp 5Ј region of the DAX1 promoter region were PCR amplified using the following six primer pairs: DAX1.1 For: 5Ј-TGAGACAGGGAAAGGGGTAAT-3Ј; DAX1.1 Rev: 5Ј-CCGGGCTCATCGCCGCACGAA-3Ј; DAX1.2 For: 5Ј-TGGTG-GATCAGTGTTGGGGC-3Ј; DAX1.2 Rev: 5Ј-CCGGGATCAGAGCCG-CACGAA-3Ј; DAX1.3 For: 5Ј-AAGCAAACGTACGCGGCAC-3Ј; DAX1.3 Rev: 5Ј-CCTCTGCGCGAAGTAGGAGC-3Ј; DAX1.4 For: 5Ј-TAGCTCAAAGCAAACGCACGTG-3Ј; DAX1.4 Rev: 5Ј-GACGC-CCAGCAGTTGCGCAC-3Ј; DAX1.5 For: 5Ј-GCCTCAGCGGGCCTGT-TGAAG-3Ј; DAX1.5 Rev: 5Ј-CCCGATGCTTTTGTGAGCTGGGAA-3Ј; DAX2.1 For: 5Ј-GCTAGCAAAGGACTCTGTGGT-3Ј; DAX2.1 Rev: 5Ј-TGTGTGGCCCACATGACTTTA-3Ј.
PCR conditions were: 1-min predenaturation at 96 C; 35 cycles of 1 min at 94 C, annealing for 1 min at 55-58 C, and extension for 1 min at 72 C; and 15-min elongation at 72 C. Buffer conditions have been described previously (18) . Direct sequencing was performed in forward and reverse using dRhodamine (PE Applied Biosystems, Foster City, CA) or Thermo Sequenase II (Amersham Pharmacia Biotech Pharmacia, Piscataway, NJ) dye terminator sequencing kits and automated sequencers (Models 373A and 377; PE Applied Biosystems, Foster City, CA).
Results

Patient Characteristics
Patient characteristics are shown in Fig. 1 .
Sporadic HH/CD (n ϭ 85).
The majority of patients investigated had sporadic (nonfamilial) reproductive disorders (n ϭ 85) (Fig. 1, left) . Isolated sporadic HH was present in 83 patients (78 men and 5 women), and CD was present in 2 boys. Of those with HH, seven had an adult-onset form of HH in which normal pubertal development occurs but HH, apulsatile LH secretion, and low testosterone develops in adult life (19) . An additional four men have the fertile eunuch syndrome. This condition is diagnosed when testicular development and spermatogenesis occurs, but systemic testosterone concentrations are insufficient for full virilization (20 -22) . In the cases of CD, pubertal development was particularly delayed, as no spontaneous testicular enlargement or sexual maturation was evident by 15 yr of age.
Familial HH/CD (n ϭ 21). DAX1 was sequenced in a total of 21 kindreds with familial forms of HH, CD, or both (Fig. 1,  right) . Families were excluded if the phenotype appeared to be inherited from the proband's father or father's family, as this precluded an X-linked gene as the cause of their condition. A total of 13 of the 21 kindreds had familial HH affecting both male and female family members. Familial CD with a classic X-linked pattern of inheritance was present in three kindreds. An additional nine families had two affected brothers in the same generation. In these cases, polymorphic microsatellite markers in the region of the DAX1 locus (DXS1202, DXS1214, DXS1226; PE Applied Biosystems) were used first to determine whether both affected sons inherited the same X-chromosome from their mother. Common descent of the same maternal X-allele (DAX1 locus) to both sons occurred in five of the nine families (two HH/CD, three CD/CD). Because a common allele segregated with the phenotype in these cases, DAX1 was considered a candidate gene, and direct sequencing was undertaken. In four families, however, affected brothers inherited different maternal X-alleles, making DAX1 an unlikely candidate gene for the phenotype seen in these cases (four CD/CD). These families were excluded from further analysis.
Mutational Analysis
Direct sequencing of the coding region, splice sites, and promoter (Ϫ240 bp) of DAX1 did not reveal any mutations in the 106 patients studied. Single nucleotide polymorphisms were detected at two sites [T114C and G498A, the A of the ATG translation initiation codon being designated ϩ1 (23)] (Table 1) . These nucleotide changes did not alter the aminoacid sequence of DAX-1 (C38C and R166R, respectively) and were detected at a similar frequency in a control population.
Discussion
Pubertal delay is a common clinical problem that is multifactorial in its origin. Environmental and nutritional factors can delay the onset and progression of puberty. A variety of hormonal disorders and acquired structural defects that affect the HPG axis can affect the process of sexual maturation (for reviews, see Refs. 24 -27) . Based on family histories and twin studies, genetic components also seem to contribute to the timing of puberty (24, 28) . The genetic basis of pubertal development is poorly understood at present. However, the coexistence of pubertal delay with variable degrees of HH in some families suggests that a common factor may be responsible for these phenotypes in a subset of patients with pubertal disorders (29) . Several single gene disorders have now been shown to cause HH in humans (30) . Affected patients may show a spectrum of mild to severe phenotypes, even within a kindred with the same mutation. Mutations in these genes may affect the HPG axis at various levels. For example, mutations in KAL (anosmin-1) cause the hypothalamic HH observed in patients with X-linked Kallmann syndrome (31, 32) , whereas mutations in the gene encoding the GnRH receptor (33, 34) primarily affect gonadotrope function. Mutations in the pituitary transcription factors PROP-1 (35) and HESX-1 (36) can also cause HH, although in these cases additional anterior pituitary hormones are affected. Defining the molecular basis of these reproductive disorders is important because approaches to treatment and counseling are different. At present, however, the underlying pathogenesis of most forms of familial or sporadic HH/CD remains unclear (16, 29, 30, 37) .
The association of HH with X-linked adrenal hypoplasia congenita and DAX1 gene mutations is well established. Although HPG activity may be relatively preserved in infancy (38 -40) , the majority of affected patients show marked HH at the expected time of puberty. In rare cases, partial pubertal development has been observed (5) . In this study, we hypothesized that mutations in DAX1 might be found in a subset of patients with HH or delayed puberty alone. In addition to its functional characteristics, the location of DAX1 on the X chromosome makes it an attractive candidate gene for a relatively common disorder because phenotypic effects are likely to be manifest in hemizygous males.
We included patients with sporadic as well as familial disorders in our cohort, as over one third of AHC patients reported to date have no other affected family members and they have de novo DAX1 mutations (4, 41, 42) . The recent report of a man who first presented at 28 yr of age with partial HH, but only mild adrenal failure, demonstrates that a reproductive phenotype may precede adrenal symptoms in certain individuals with DAX1 mutations (13) . In addition, several females with sporadic HH were included in this study following the report of a woman with a homozygous DAX1 mutation who has HH and normal adrenal function (17) . Finally, we included families in which both males and females have HH, as extreme pubertal delay has been reported in some female carriers of DAX1 mutations (12) . Such a phenotype in heterozygous women could result from skewed X-inactivation.
Identifying patients with DAX1 mutations among those attending clinics for HH is important for a variety of reasons. First, different approaches to treatment might be needed for such patients, given their variable response to GnRH (10 -13) . Although data are limited at present, spermatogenesis may be affected by DAX1 mutations in humans as it is in mice (15) , and the response to gonadotropin treatment may be impaired (12, 13) . Second, these patients may have subclinical adrenal failure that could become clinically significant if left undiagnosed, as highlighted by the patient who presented with increasing symptoms of adrenal insufficiency in his late twenties (13) . Third, when the genetic basis for a disorder is identified in a proband, appropriate genetic counseling can be provided to additional family members. In the case of DAX1 mutations, female carriers of the mutation can be advised regarding testing of male offspring for adrenal insufficiency. Boys with DAX1 mutations can be given glucocorticoids and mineralocorticoids, as indicated, and hormonal replacement can be provided at the time of puberty. Finally, any mutations found to be associated with a varied reproductive phenotype could provide important insight into the structure and function of the DAX-1 protein. The majority of DAX1 mutations reported to date are frameshift or nonsense mutations (3, 4) . Missense mutations, which might cause relatively subtle alterations in protein function, have been rare among the early, classical cases of AHC and seem to be localized to the putative ligand-binding (carboxyterminal) domain of DAX-1 (1, 5, 6, 38, (43) (44) (45) . A direct sequencing approach was used, therefore, to optimize our sensitivity for detecting missense mutations. Although two previously reported polymorphisms were discovered in a significant number of patients (4), no DAX1 mutations were found in the 106 patients studied. These findings indicate that DAX1 mutations are unlikely to be a significant cause of HH or pubertal delay in the absence of a personal or family history of adrenal failure. 
